VASO VASO Corp

CIK 0000839087 12 ready 8-Ks latest May 8, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 12

Latest filing May 8, 2026, 7:59 PM ET

Top materiality 0.90

Event mix m_and_a ×6 · other_material ×4 · leadership ×2

Sentiment 1 pos · 1 neg · 10 neu

Executive change recent →

Recent 8-K filings for VASO

Highest-materiality recent filing

Vaso Corporation terminates business combination agreement with Achari Ventures Holdings Corp. I

September 19, 2024, 7:59 PM ET M&A materiality 0.90 negative item 1.02 item 8.01 item 9.01

Vaso terminated the Business Combination Agreement with Achari on September 17, 2024.
The agreement dated December 6, 2023, would have made Vaso a wholly owned subsidiary of Achari.

Read filing →

May 8, 2026, 7:59 PM ET other material materiality 0.35 neutral item 5.02 item 9.01

Vaso Corp. agrees to pay $175,000 incentive to subsidiary president for strategic goals

Peter Castle, President of VasoTechnology, eligible for $175,000 incentive payment.
February 12, 2026, 6:59 PM ET other material materiality 0.15 neutral item 5.03 item 9.01 ◈ Governance Changes

Vaso Corporation amends Bylaws to add COO, remove written consent, allow virtual meetings

Removed stockholder right to act by written consent; now requires in-person or virtual meeting vote.
December 19, 2025, 6:59 PM ET other material materiality 0.15 neutral item 5.07 item 9.01

Vaso shareholders elect three directors, approve Say on Pay, choose triennial frequency

Elected directors Behnam Movaseghi (103.7M for), Jane Moen (109.4M for), Leon Dembo (103.6M for) to three-year terms.
November 20, 2025, 6:59 PM ET M&A materiality 0.25 neutral item 8.01 item 9.01

Vaso sells VasoHealthcare IT to Nano-X for up to $800K; <5% of total revenue

Sale consideration up to $800K: $200K at closing, $600K earnout tied to post-close performance.
January 3, 2025, 6:59 PM ET leadership materiality 0.50 neutral item 5.02 ◈ executive_change ×5

Vaso Corp appoints Jane Moen COO; Jonathan Newton named sole CFO and Secretary

Jane Moen, age 45, appointed COO effective Jan 1, 2025; she remains President of Vaso Healthcare subsidiary.
September 19, 2024, 7:59 PM ET M&A materiality 0.90 negative item 1.02 item 8.01 item 9.01

Vaso Corporation terminates business combination agreement with Achari Ventures Holdings Corp. I

Vaso terminated the Business Combination Agreement with Achari on September 17, 2024.
September 10, 2024, 7:59 PM ET M&A materiality 0.75 neutral item 5.07 item 8.01 item 9.01

Vaso shareholders approve business combination with Achari; Nasdaq listing expected

Special meeting held Sep 10, 2024; quorum of 129,015,962 shares (73.6% of voting power).
August 28, 2024, 7:59 PM ET M&A materiality 0.50 neutral item 8.01 item 9.01

Vaso adjourns special meeting on business combination to September 10, 2024

Special meeting originally Aug 26, 2024 adjourned; will reconvene at Lever House, New York at 10:00 a.m. ET.
August 23, 2024, 7:59 PM ET M&A materiality 0.60 neutral item 8.01 item 9.01

Vaso provides pro forma combined financials for Achari merger; 2023 revenue $81.0M, net loss $0.7M

Six months ended June 30, 2024 pro forma combined revenue $39.0M, net loss $1.5M.
December 8, 2023, 6:59 PM ET M&A materiality 0.75 positive item 1.01 item 7.01 item 9.01 ◈ Material Agreements

Vaso Corporation to merge with SPAC Achari, uplist to Nasdaq at $176M valuation

Vaso to combine with Achari Ventures (AVHI) at $176M equity value ($10/share); expected close Q1 2024.
April 3, 2023, 7:59 PM ET leadership materiality 0.25 neutral item 5.02 ◈ executive_change

Vaso Corporation appoints Leon Dembo as independent director

Leon Dembo appointed to Vaso's Board as independent director, effective April 3, 2023.
September 16, 2022, 7:59 PM ET other material materiality 0.50 neutral item 4.01 item 9.01

Vaso Corporation dismisses MaloneBailey, appoints UHY as new auditor

Audit committee approved UHY engagement on Aug 24, 2022; UHY accepted Sep 12, 2022.

Executive changes

Appointed

Jonathan Newton

Secretary

VASO · VASO Corp

Effective: 2025-01-01
Filed: January 3, 2025, 6:59 PM ET

was also appointed as the Secretary of the Company

Departed

Peter C. Castle

Chief Operating Officer

VASO · VASO Corp

Effective: 2025-01-01
Successor: Jane Moen
Filed: January 3, 2025, 6:59 PM ET

Mr. Peter C. Castle, previously Chief Operating Officer, will continue in his capacity as President of the Company’s wholly-owned subsidiary, VasoTechnology, Inc.

Appointed

Jane Moen

Chief Operating Officer

VASO · VASO Corp

Effective: 2025-01-01
Filed: January 3, 2025, 6:59 PM ET

Effective January 1, 2025, the Board of Directors appointed Jane Moen as its Chief Operating Officer.

Role change

Jonathan Newton

Chief Financial Officer and Treasurer

VASO · VASO Corp

Effective: 2025-01-01
Filed: January 3, 2025, 6:59 PM ET

Jonathan Newton, previously Co-Chief Financial Officer and Treasurer of the Company, continues as the company’s sole Chief Financial Officer and Treasurer and was also appointed as the Secretary of the Company.

Departed

Michael Beecher

Co-Chief Financial Officer and Secretary

VASO · VASO Corp

Effective: 2025-01-01
Successor: Jonathan Newton
Filed: January 3, 2025, 6:59 PM ET

Effective January 1, 2025, Michael Beecher, previously Co-Chief Financial Officer and Secretary, ceased serving in those roles but will continue to be employed by the Company as a financial advisor.

Appointed

Leon Dembo

independent director

VASO · VASO Corp

Effective: 2023-04-03
Filed: April 3, 2023, 7:59 PM ET

On March 23, 2023, Leon Dembo (68 years of age) was appointed by the Board of Directors as an independent director of the Company, effective as of April 3, 2023 to serve in Class II until the Annual Meeting of Shareholders in 2025.

Materiality & sentiment trend

Max materiality 0.90 · Median 0.50 · Most common event m_and_a

1 positive 1 negative 10 neutral

source · VASO on sec.gov